Clinical Utility of Subcutaneous Factor VIII Replacement Therapies in Hemophilia A: A Review of the Evidence

Clinical Utility of Subcutaneous Factor VIII Replacement Therapies in Hemophilia A: A Review of the Evidence

Yesim Dargaud,1,2 Maissa Janbain3 1UR4609 Hemostase et Thrombose, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Est, Lyon, France; 2Unité d’Hémostase Clinique, Hôpital Cardiologique Louis Pradel, Hospices Civils de Lyon, Lyon, France; 3Hematology Department, Tulane School of Medicine, N...

Full description

Bibliographic Details
Main Authors: Dargaud Y, Janbain M
Format: Article
Language:English
Published: Dove Medical Press 2021-12-01
Series:Journal of Blood Medicine
Subjects:
hemophilia a
factor viii
recombinant von willebrand factor fragment
prophylaxis
subcutaneous injection
Online Access:https://www.dovepress.com/clinical-utility-of-subcutaneous-factor-viii-replacement-therapies-in--peer-reviewed-fulltext-article-JBM

Internet

https://www.dovepress.com/clinical-utility-of-subcutaneous-factor-viii-replacement-therapies-in--peer-reviewed-fulltext-article-JBM

Similar Items